Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAC) is intensively used for the treatment of primary breast cancer. In our previous studies, we reported that clinical tumor response to NAC is associated with the change of multidrug resistance (MDR) gene expression in tumors after chemotherapy. In this study we performed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Litviakov, Nikolai V., Cherdyntseva, Nadezhda V., Tsyganov, Matvey M., Slonimskaya, Elena M., Ibragimova, Marina K., Kazantseva, Polina V., Kzhyshkowska, Julia, Choinzonov, Eugeniy L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884957/
https://ncbi.nlm.nih.gov/pubmed/26799285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6953
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi